Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 06:00 source : Www.biospace.com save search
Intra-Cellular Therapies Prices Public Offering of Common Stock - April 18, 2024
Published: 2024-04-18 (Crawled : 06:00) - biospace.com/
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 0.43%
H: 0.0%
C: 0.0%
ITCI 1 d | $72.29 0.4% 0.4% 2.2M
|
Health Technology
|
| O: -4.8%
H: 0.0%
C: 0.0%
offering
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-15 (Crawled : 06:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
XOMA | News | $24.97 1.55% 1.52% 17K
|
Health Technology
|
| O: -2.63%
H: 1.39%
C: -3.3%
biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-15 (Crawled : 06:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
XOMA | News | $24.97 1.55% 1.52% 17K
|
Health Technology
|
| O: -2.63%
H: 1.39%
C: -3.3%
companies biopharma platform
Rare Disease Drug Development Urgently Needs More Funding, Experts Say
Published: 2024-02-29 (Crawled : 06:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
rare drug disease
Baisong Mei’s Immigrant Journey Through American Biopharma
Published: 2024-02-29 (Crawled : 06:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
biopharma
GSK, Sanofi Exit Nigerian Market Amid Lingering Foreign Exchange Crisis
Published: 2024-02-28 (Crawled : 06:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
sanofi market
Opinion: 2024 Will Be a Buyers’ Market in Biopharma. It Already Is.
Published: 2024-02-21 (Crawled : 06:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
market
Adicet Bio, Inc. Announces Pricing of Public Offering - Jan 23, 2024
Published: 2024-01-23 (Crawled : 06:00) - biospace.com/
ACET | $1.95 -3.7% -3.85% 730K
|
Health Technology
|
| O: 2.95%
H: 0.0%
C: 0.0%
offering
Global Regulators Increase CAR T Scrutiny in Wake of FDA’s Investigation
Published: 2024-01-22 (Crawled : 06:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
global
NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
Published: 2024-01-03 (Crawled : 06:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: -0.26%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: 0.0%
life year nextgen sciences
Opinion: Space Is the Next Frontier in Drug Discovery
Published: 2024-01-02 (Crawled : 06:00) - biospace.com/
MEDE | News | $0.51 0% 500
|
n/a
| Email alert
Add to watchlist
drug frontier space
New Novotech Report Finds 1,000 HIV Clinical Trials Globally
Published: 2023-12-29 (Crawled : 06:00) - biospace.com/
MEDE | News | $0.51 0% 500
|
n/a
| Email alert
Add to watchlist
report trials hiv
LegoChem Biosciences Announces License Agreement for LCB84 Trop2-Targeted ADC
Published: 2023-12-26 (Crawled : 06:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
lcb84 license agreement
Medicenna Extends Period to Exercise Certain Warrants - December 22, 2023
Published: 2023-12-22 (Crawled : 06:00) - biospace.com/
MDNAF | $1.24 -17.54% 67K
|
n/a
|
| O: -1.41%
H: 9.08%
C: 1.96%
Opinion: To Alleviate Supply Chain Shortages, Companies Should Share Data
Published: 2023-12-06 (Crawled : 06:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.77%
H: 0.49%
C: 0.49%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
companies
Innovent Presents Clinical Data Update of IBI351 (KRAS G12C Inhibitor) Monotherapy in Lung Cancer and Colorectal Cancer at ESMO Asia Congress 2023
Published: 2023-12-01 (Crawled : 06:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: -0.05%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.15%
H: 0.35%
C: -0.74%
ibi351 lung congress update cancer asia
5 Cancer Vaccines to Watch in 2024
Published: 2023-11-20 (Crawled : 06:00) - biospace.com/
NIPNF | $68.91 -52.94% 120
|
Technology Services
| Email alert
Add to watchlist
cancer
Bristol Myers Squibb Prices $4.5 Billion of Senior Unsecured Notes
Published: 2023-10-31 (Crawled : 06:00) - biospace.com/
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 0.83%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.25%
H: 0.54%
C: 0.29%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
J&J’s Christopher Whelan on How—and Why—13 Companies Teamed up to Tackle Proteomics
Published: 2023-10-18 (Crawled : 06:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.83%
H: 0.35%
C: -1.72%
companies
FDA Action Alert: Merck, Ardelyx, BioMarin and More
Published: 2023-10-16 (Crawled : 06:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
fda
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.